Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA approves Royce's generic narcotic pain reliever

Jan. 24, 1997

Royce Laboratories receives FDA approval for alprazolam

Jan. 24, 1997

SIBIA receives patent coverage for antiparkinson compounds

Jan. 24, 1997

Glaxo Wellcome selects anticonvulsant compound for further study

Jan. 24, 1997

New AMPA receptor modulator described by Servier

Jan. 23, 1997

BMS cognition enhancer not superior to placebo in clinical study

Jan. 23, 1997

Clinical results of gabapentin in ALS reported

Jan. 23, 1997

Glaxo Wellcome claims new formulation of anxiolytic agent

Jan. 23, 1997

Neurex compound headed for pivotal trials in head trauma

Jan. 23, 1997

5-HT3/5-HT4 receptor ligands disclosed by Synthelabo

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...